Name

MVP

Alternate names

None

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for MVP

Name

Alternate Names

Ametycine
Mito-Medac
Mitocin
Mitocin-C
MitoExtra
Mitomycin-C
Mitomycin-X
Mutamycin
Mutamycine

Abbreviations

MITC
Mito
MITO-C
MMC
MTC

Category

Chemotherapy

Subcategory

Alkylating agent
Antibiotic

NSC Number

26980
026980

Primary Site

Breast
Cervical cancer
Gastric cancer
Head and Neck (in combination with radiation therapy)
Non-small cell lung cancer (NSCLC)
Pancreatic cancer
Superficial bladder cancer

Histology

None

Remarks

FDA approved for treatmen of many cancers.

Coding

This drug should be coded

Name

Alternate Names

Cis-Platin
Cis-Platinum II#
Cisplatino (Spanish)
Cisplatinum
Cisplatyl
Neoplatin
Peyrone's chloride
Platinex
Platinol
Platinol-AQ
Platinol-AQ VHA Plus
Platinum

Abbreviations

CACP
CDDP
Cis-DDP
CPD
CPDC
CPDD
CPPD
DDP

Category

Chemotherapy

Subcategory

Alkylating agent
Platinum analog

NSC Number

119875

Primary Site

Bladder
ovarian
testicular cancer

Histology

None

Remarks

An alkylating antineoplastic agent. FDA approved uses on bladder, ovarian and testicular cancer; miscellaneous agent.

Coding

This drug should be coded

Name

Alternate Names

29060-LE
Alkaban
LE-29060
Velban
Velbe
Velsar
Vinblastine
Vinblastine sulfate

Abbreviations

VBL
VELB
VLB

Category

Chemotherapy

Subcategory

Plant alkaloid

NSC Number

049842
49842

Primary Site

None

Histology

None

Remarks

A cell cycle specific chemotherapeutic agent; vinca plant alkaloid; mitotic inhibitor. FDA approved uses in 3rd line breast cancer, choriocarcinoma, palliative in stages III and IV Hodgkin's lymphoma, Kaposi's sarcoma, mycosis fungoides, palliative in non-Hodgkin's histiocytic/lymphocytic lymphoma, and advanced testicular carcinoma.

Coding

This drug should be coded
Glossary